Literature DB >> 2292204

In vitro studies on the cardiotoxicity of chemotherapeutics.

I Löw-Friedrich1, F von Bredow, W Schoeppe.   

Abstract

The de novo synthesis of 'shock proteins' is a cellular reaction towards toxic agents. Therefore, the induction of 'shock proteins' serves as a detector of toxicity on the level of protein synthesis. We investigated the effects of chemotherapeutics on cultured cardiac myocytes with this test system. Cisplatin (greater than or equal to 16 mumol/l) and methotrexate (greater than or equal to 1.4 mumol/l) evoked the de novo formation of a 30-kilodalton 'shock protein'. Doxorubicin (80-0.8 mumol/l) and daunomycin (90-0.9 mumol/l) inhibited protein synthesis almost completely. The other chemotherapeutic drugs tested did not influence heart cell protein formation even at concentrations widely above the pharmacological range. Our results indicate that the anthracyclines probably exert cardiotoxicity by depression of protein synthesis. Cisplatin and methotrexate are potentially cardiotoxic at high concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292204     DOI: 10.1159/000238798

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  2 in total

1.  Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.

Authors:  T Schilling; K B Keppler; M E Heim; G Niebch; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 2.  Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

Authors:  Maurizio Galderisi; Francesco Marra; Roberta Esposito; Vincenzo Schiano Lomoriello; Moira Pardo; Oreste de Divitiis
Journal:  Cardiovasc Ultrasound       Date:  2007-01-25       Impact factor: 2.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.